Cento

Centogene is a commercial-stage life science company focused on transforming data into actionable medical decisions for patients with rare genetic diseases. The company leverages its proprietary CentoMD platform, one of the world's largest curated mutation databases for rare diseases, to provide diagnostic testing and support pharmaceutical partners in drug discovery and development. Centogene offers a comprehensive suite of genetic, proteomic, and metabolic testing services to physicians and patients globally. By integrating clinical and genetic data, the company accelerates the identification of biomarkers and the development of new therapeutic solutions for orphan diseases.